These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15761445)
1. Redefining the dermatologist-academy-industry relationship: an open letter. Craft N J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):536-7; discussion 537. PubMed ID: 15761445 [No Abstract] [Full Text] [Related]
2. Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry. Tohen M Epidemiol Psichiatr Soc; 2007; 16(3):197-8. PubMed ID: 18020191 [TBL] [Abstract][Full Text] [Related]
3. Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? Barbui C; Tansella M Epidemiol Psichiatr Soc; 2007; 16(3):189-91. PubMed ID: 18020189 [No Abstract] [Full Text] [Related]
4. Share and share alike. Bradley D Nat Rev Drug Discov; 2005 Mar; 4(3):180. PubMed ID: 15803525 [No Abstract] [Full Text] [Related]
5. Faculties of health sciences and the pharmaceutical industry: an effective partnership. Forrest JB CMAJ; 1994 Nov; 151(9):1320-2. PubMed ID: 7954182 [No Abstract] [Full Text] [Related]
6. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
7. IAP and industry relationship guidelines 2003. Bodhankar U; Patil Y Indian Pediatr; 2003 Sep; 40(9):847-51. PubMed ID: 14530544 [No Abstract] [Full Text] [Related]
8. Bridging the divide. Nat Rev Drug Discov; 2005 Mar; 4(3):177. PubMed ID: 15770774 [No Abstract] [Full Text] [Related]
9. The patient-physician-industry-government partnership: a societal good. Frishman WH Am J Med; 2009 Oct; 122(10):886-7. PubMed ID: 19786152 [No Abstract] [Full Text] [Related]
10. Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry. Moncrieff J Epidemiol Psichiatr Soc; 2007; 16(3):192-6. PubMed ID: 18020190 [TBL] [Abstract][Full Text] [Related]
11. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
12. Your soul for a pen? DeMaria AN J Am Coll Cardiol; 2007 Mar; 49(11):1220-2. PubMed ID: 17367667 [No Abstract] [Full Text] [Related]
13. British Association of University Teachers of Dermatology (BAUTOD). Marks R Br J Dermatol; 1992 Feb; 126(2):201-2. PubMed ID: 1536790 [No Abstract] [Full Text] [Related]
14. [The common future of urology and the pharmaceutical industry]. Odenthal G Urologe A; 2006 Sep; 45 Suppl 4():41-3. PubMed ID: 16955325 [No Abstract] [Full Text] [Related]
18. Reframing relations with Pharma. Chair of RCP working party responds to editorial. Horton R BMJ; 2009 Feb; 338():b767. PubMed ID: 19240100 [No Abstract] [Full Text] [Related]
19. Entrepreneurship in the medical academy: possibilities and challenges in commercialization of research discoveries. Loscalzo J Circulation; 2007 Mar; 115(12):1504-7. PubMed ID: 17389277 [No Abstract] [Full Text] [Related]
20. Drug companies, dermatologists, and the patient. Rapaport MJ; Franzblau M J Am Acad Dermatol; 2007 Feb; 56(2):333-4. PubMed ID: 17224376 [No Abstract] [Full Text] [Related] [Next] [New Search]